DrugPatentWatch Database Preview
Litigation Details for ASTRAZENECA PHARMACEUTICALS LP v. AGILA SPECIALTIES, INC (D.N.J. 2015)
» See Plans and Pricing
ASTRAZENECA PHARMACEUTICALS LP v. AGILA SPECIALTIES, INC (D.N.J. 2015)
| Docket | Start Trial | Date Filed | 2015-08-06 |
| Court | District Court, D. New Jersey | Date Terminated | 2017-10-27 |
| Cause | 35:271 Patent Infringement | Assigned To | Renee Marie Bumb |
| Jury Demand | None | Referred To | Karen M. Williams |
| Parties | AGILA SPECIALTIES, INC; ASTRAZENECA AB; ASTRAZENECA PHARMACEUTICALS LP; ASTRAZENECA UK LIMITED; INNOPHARMA LICENSING LLC; MYLAN INC.; MYLAN INSTITUTIONAL LLC; MYLAN LABORATORIES LIMITED; MYLAN PHARMACEUTICALS INC.; ONCO THERAPIES LIMITED; TEVA PHARMACEUTICALS USA, INC. | ||
| Patents | 6,417,191; 6,774,122; 7,456,160; 8,329,680; 8,466,139 | ||
| Attorneys | ALLISON LINDA HOLLOWS; ARNOLD B. CALMANN; CAITLIN P. HOGAN; CAROLYN SUZANNE WALL; CHRISTOPHER ROBERT KINKADE; GUILLERMO CARLO ARTILES; JEFFREY S. SOOS; JOHN EDMUND FLAHERTY; KAREN A. CONFOY; KATHERINE ANN ESCANLAR; MAYRA VELEZ TARANTINO; MICHAEL E. PATUNAS; RAVIN R. PATEL; STEVEN J. DAROCI; STEVEN JAMES LINK | ||
| Firms | Fox Rothschild LLP; Fox Rothschild LLP, Pc; McCarter and English, LLP; O'Melveny & Myers LLP; Patunas Law LLC; Patunas Tarantino LLC | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ASTRAZENECA PHARMACEUTICALS LP v. AGILA SPECIALTIES, INC
The small molecule drugs covered by the patents cited in this case are Start Trial , Start Trial , Start Trial , and Start Trial .
Details for ASTRAZENECA PHARMACEUTICALS LP v. AGILA SPECIALTIES, INC (D.N.J. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-09-21 | 10 | THE PATENTS-IN-SUIT 26. United States Patent No. 6,774,122 (the “’122 Patent”), entitled… the expiration of AstraZeneca’s U.S. Patent Nos. 6,774,122, 7,456,160, 8,329,680, and 8,466,139. … COUNT I: INFRINGEMENT OF U.S. PATENT NO. 6,774,122 40. Plaintiffs hereby reallege… U.S. PATENT NO. 6,774,122 51. Plaintiffs hereby reallege… This is a civil action for patent infringement under the patent laws of the United States, Title | External link to document | |
| 2016-09-02 | 120 | Formulations, 52 J. Pharm. Sci. Tech. • U.S. Patent No. 6,417,191, AZF2_00005454–66 …Statement for U.S. Patent Nos. 6,774,122 (“the ’122 Patent”), 7,456,160 (“the ’160 Patent”), 8,329,680 (… (“the ’680 Patent”), and 8,466,139 (“the ’139 Patent”) (collectively, “the Patents-in-Suit”) in the…disputed term in the ’122 Patent (Exhibit A), the ’160 Patent (Exhibit B), the ’680 Patent (Exhibit C), and…these Hatch-Waxman patent actions, Plaintiffs are asserting infringement of the Patents-in-Suit against | External link to document | |
| 2017-01-04 | 197 | enjoined from infringing United States Patent Numbers 6,774,122, 7,456,160, 8,329,680 and 8,466,139, on…2015 27 October 2017 1:15-cv-06039 830 Patent None District Court, D. New Jersey | External link to document | |
| 2015-12-07 | 29 | the expiration of the Plaintiff’s U.S. Patent Nos. 6,774,122, 7,456,160, 8,329,680, and 8,466,139. …law and fact in so much as they are actions for patent infringement Case 1:15-cv-06039-RMB-KMW Document…2015 27 October 2017 1:15-cv-06039 830 Patent None District Court, D. New Jersey | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
